RecruitingNCT05647109
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Department of Obstetrics & Gynecology ,Peking University People's Hospital
Sponsor
Peking University People's Hospital
Enrollment
244 participants
Start Date
Sep 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
To construct a prediction model of progesterone sensitivity in patients with endometrial cancer treated with fertility preservation
Eligibility
Sex: FEMALEMin Age: 17 YearsMax Age: 45 Years
Inclusion Criteria4
- Have a confirmed pathological diagnosis based upon hysteroscopy: atypical endometrial hyperplasia or histologically prove well-differentiated EEC G1 without myometrial invasion
- No signs of suspicious extrauterine involvement on enhanced magnetic resonance imaging (MRI) or enhanced computed tomography (CT) or ultrasound
- Have a desire for remaining reproductive function or uterus
- Good compliance with adjunctive treatment and follow-up
Exclusion Criteria7
- Acute liver disease or liver tumor (benign or malignant) or renal dysfunction
- Pregnancy or potential pregnancy
- Confirmed diagnosis of any cancer in reproductive system
- Acute severe disease such as stroke or heart infarction or a history of thrombosis disease
- Hypersensitivity or contradiction for using MPA or MA
- With other factors of reproductive dysfunction;
- Strong request for uterine removal or other conservative treatment
Interventions
OTHERNo intervention
No intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05647109
Related Trials
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
NCT0505172224 locations
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
NCT063791132 locations
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
NCT053169352 locations
Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
NCT056757871 location
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
NCT034632521 location